Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA)

86 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2024.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17.7M shares of 54.8M outstanding shares and own 32.27% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.25M shares), DISCIPLINED GROWTH INVESTORS INC /MN (1.94M shares), Chescapmanager LLC (1.7M shares), FARALLON CAPITAL MANAGEMENT LLC (1.56M shares), BNP PARIBAS FINANCIAL MARKETS (1.08M shares), RENAISSANCE TECHNOLOGIES LLC (1.07M shares), TWO SIGMA ADVISERS, LP (862K shares), BlackRock Inc. (745K shares), MILLENNIUM MANAGEMENT LLC (587K shares), and BANK OF AMERICA CORP /DE/ (478K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.